FDA approves Novartis drug Cosentyx to treat hidradenitis suppurativa patients
Phase III data showed Cosentyx can provide rapid relief from symptoms of hidradenitis suppurativa as early as Week 2
The US Food and Drug Administration...
MHRA approves new dose for treating alopecia areata
The new medication is said to reduce inflammation
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised a new drug today (1 November) to...
Elsevier unveiled PharmaPendium: a drug development decision-making platform
The new drug research initiative provides preclinical and clinical data that enable researchers to make informed decisions regarding drug enhancement
The global company in information...
Drug pricing, reimbursement issues to remain key barriers to pharmaceutical sector growth: GlobalData
GlobalData has identified drug pricing and reimbursement-related concerns as the key impediment to the pharmaceutical industry’s growth in 2022.
These barriers could even force pharmaceutical...
Diabetes drug prescriptions rises eight million since 2015, NHS report says
Nearly 60 million drugs were used to treat people with diabetes in England last year, increasing eight million since 2015-16, a report by the...